000 01342 a2200397 4500
005 20250513165308.0
264 0 _c19990318
008 199903s 0 0 dut d
022 _a0028-2162
040 _aNLM
_beng
_cNLM
100 1 _ade Jong-van den Berg, L T
245 0 0 _a[Thalidomide once more in the spotlight].
_h[electronic resource]
260 _bNederlands tijdschrift voor geneeskunde
_cNov 1998
300 _a2509-12 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aBone Marrow Transplantation
_xadverse effects
650 0 4 _aContraindications
650 0 4 _aDrug Approval
_xlegislation & jurisprudence
650 0 4 _aDrug and Narcotic Control
_xlegislation & jurisprudence
650 0 4 _aFemale
650 0 4 _aGraft vs Host Disease
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aNetherlands
650 0 4 _aPregnancy
650 0 4 _aPrenatal Exposure Delayed Effects
650 0 4 _aStomatitis, Aphthous
_xdrug therapy
650 0 4 _aTeratogens
_xpharmacology
650 0 4 _aThalidomide
_xpharmacology
650 0 4 _aTumor Necrosis Factor-alpha
_xantagonists & inhibitors
650 0 4 _aUnited States
700 1 _aRutgers, J
700 1 _aCornel, M C
773 0 _tNederlands tijdschrift voor geneeskunde
_gvol. 142
_gno. 46
_gp. 2509-12
999 _c9989616
_d9989616